A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

Friday, the FDA granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the ...

Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a ...

An updated COVID-19 vaccine from Novavax got the green light on Friday from the FDA. The protein-based vaccine is for use in ...

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and ...

When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here's what ...

Also Read: FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax’s Shot. “Our updated vaccine targets JN.1, the ‘parent strain’ of currently circulating ...